Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized
inpatients. Risk stratification and prophylactic measures have good evidence supporting …

Abstract BACKGROUND: Hospital‐acquired (HA) venous thromboembolism (VTE) is a
common source of morbidity/mortality. Prophylactic measures are underutilized. Available …

Hospital acquired venous thromboembolism (VTE) is a major source of morbidity and
mortality, yet proven prevention measures are often underutilized. The lack of a validated …

The 7th conference of the American College of Chest Physicians (ACCP7) provides
recommendations on the type, dose, and duration of thromboprophylaxis in hospitalized …

BACKGROUND: Fewer than half of eligible hospitalized medical patients receive
appropriate venous thromboembolism (VTE) prophylaxis. One reason for this low rate is the …

Venous thromboembolism (VTE) is considered to be the most common preventable cause of
hospital-related death. Hospitalized patients undergoing major Surgery and hospitalized …

Background Hospitalized medical patients are at risk for venous thromboembolism (VTE).
Universal application of pharmacological thromboprophylaxis has the potential to place a …

Background Venous thromboembolism (VTE) is a common cause of preventable harm for
hospitalised patients. Over the past decade, numerous intervention types have been …

The annual number of US venous thromboembolism (VTE) events, the number of potentially
preventable events, and the effect of hospitalization-based prophylaxis are uncertain. We …

Background Information about the variation in the risk for venous thromboembolism (VTE)
and in prophylaxis practices around the world is scarce. The ENDORSE (Epidemiologic …